Conversely, Yang et al. suggested that LHPP mRNA expression was reduced in NSCLC tissues, and the miR-217/LHPP [32] axis was also activated in the reduction of cisplatin resistance in NSCLC. The gene discussed is LHPP; the disease is non-small cell lung carcinoma.